These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33471934)

  • 1. Nicotinamide (vitamin B3) treatment improves response to G-CSF in severe congenital neutropenia patients.
    Deordieva E; Shvets O; Voronin K; Maschan A; Welte K; Skokowa J; Novichkova G; Shcherbina A
    Br J Haematol; 2021 Feb; 192(4):788-792. PubMed ID: 33471934
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of a Patient With Congenital Biallelic CSF3R Mutation With GM-CSF.
    Yilmaz Karapinar D; Özdemir HH; Akinci B; Yaşar AŞ; Siviş ZÖ; Onay H; Özkinay F
    J Pediatr Hematol Oncol; 2020 Apr; 42(3):e164-e166. PubMed ID: 30499904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy.
    Freedman MH; Bonilla MA; Fier C; Bolyard AA; Scarlata D; Boxer LA; Brown S; Cham B; Kannourakis G; Kinsey SE; Mori PG; Cottle T; Welte K; Dale DC
    Blood; 2000 Jul; 96(2):429-36. PubMed ID: 10887102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocytoclastic vasculitis in patients with severe congenital neutropenia.
    Kilic SS; Mustafayeva S; Ipek K; Adim SB
    J Trop Pediatr; 2010 Oct; 56(5):359-62. PubMed ID: 20100783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of pegfilgrastim in children with severe congenital neutropenia: clinical and pharmacokinetic data.
    Fioredda F; Lanza T; Gallicola F; Riccardi F; Lanciotti M; Mastrodicasa E; Signa S; Zanardi S; Calvillo M; Dufour C
    Blood; 2016 Oct; 128(17):2178-2181. PubMed ID: 27621310
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of receptors for granulocyte colony-stimulating factor on neutrophils from patients with severe congenital neutropenia and cyclic neutropenia.
    Kyas U; Pietsch T; Welte K
    Blood; 1992 Mar; 79(5):1144-7. PubMed ID: 1371412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.
    Donadieu J; Leblanc T; Bader Meunier B; Barkaoui M; Fenneteau O; Bertrand Y; Maier-Redelsperger M; Micheau M; Stephan JL; Phillipe N; Bordigoni P; Babin-Boilletot A; Bensaid P; Manel AM; Vilmer E; Thuret I; Blanche S; Gluckman E; Fischer A; Mechinaud F; Joly B; Lamy T; Hermine O; Cassinat B; Bellanné-Chantelot C; Chomienne C;
    Haematologica; 2005 Jan; 90(1):45-53. PubMed ID: 15642668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment.
    Ward AC; van Aesch YM; Gits J; Schelen AM; de Koning JP; van Leeuwen D; Freedman MH; Touw IP
    J Exp Med; 1999 Aug; 190(4):497-507. PubMed ID: 10449521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.
    Tidow N; Pilz C; Teichmann B; Müller-Brechlin A; Germeshausen M; Kasper B; Rauprich P; Sykora KW; Welte K
    Blood; 1997 Apr; 89(7):2369-75. PubMed ID: 9116280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe osteopenia in a young boy with Kostmann's congenital neutropenia treated with granulocyte colony-stimulating factor: suggested therapeutic approach.
    Sekhar RV; Culbert S; Hoots WK; Klein MJ; Zietz H; Vassilopoulou-Sellin R
    Pediatrics; 2001 Sep; 108(3):E54. PubMed ID: 11533372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report: Association between cyclic neutropenia and SRP54 deficiency.
    Erdős M; Boyarchuk O; Maródi L
    Front Immunol; 2022; 13():975017. PubMed ID: 36159802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of different genetic mutations on granulocyte development and G-CSF responsiveness in congenital neutropenia.
    Meng X; Zhang H; Dong L; Min Q; Yu M; Li Y; Liu L; Wang W; Ying W; Sun J; Wang JY; Hou J; Wang X
    Blood Adv; 2024 Apr; 8(7):1667-1682. PubMed ID: 38286463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital Neutropenia and Rare Functional Phagocyte Disorders in Children.
    Walkovich K; Connelly JA
    Hematol Oncol Clin North Am; 2019 Jun; 33(3):533-551. PubMed ID: 31030818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis in severe congenital neutropenia treated with granulocyte colony-stimulating factor.
    Bishop NJ; Williams DM; Compston JC; Stirling DM; Prentice A
    Br J Haematol; 1995 Apr; 89(4):927-8. PubMed ID: 7539627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe congenital neutropenia unresponsive to G-CSF.
    Ryan M; Will AM; Testa N; Hayworth C; Darbyshire PJ
    Br J Haematol; 1995 Sep; 91(1):43-5. PubMed ID: 7577650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular characteristics of Thai patients with
    Ittiwut R; Sengpanich K; Lauhasurayotin S; Ittiwut C; Shotelersuk V; Sosothikul D; Suphapeetiporn K
    J Clin Pathol; 2022 Feb; 75(2):99-103. PubMed ID: 33318085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trisomy 21 and isodicentric chromosome 21 in Kostmann syndrome following treatment with G-CSF.
    Roland B; Woodman RC; Jorgenson K; Pinto A
    Cancer Genet Cytogenet; 2001 Apr; 126(1):78-80. PubMed ID: 11343785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital Neutropenia Patient With Hypomorphic Biallelic CSF3R Mutation Responding to GCSF.
    Yilmaz Karapinar D; Akinci B; Şahin Yaşar A; Hekimci Özdemir H; Önder Siviş Z; Onay H; Özkinay F
    J Pediatr Hematol Oncol; 2019 Apr; 41(3):e190-e192. PubMed ID: 30028820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias.
    Bonilla MA; Dale D; Zeidler C; Last L; Reiter A; Ruggeiro M; Davis M; Koci B; Hammond W; Gillio A; Welte K
    Br J Haematol; 1994 Dec; 88(4):723-30. PubMed ID: 7529539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.
    Welte K; Zeidler C; Reiter A; Müller W; Odenwald E; Souza L; Riehm H
    Blood; 1990 Mar; 75(5):1056-63. PubMed ID: 1689595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.